These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A surprisingly potent nucleoside analogue.
    Author: Torres G.
    Journal: GMHC Treat Issues; 1996 Feb; 10(2):8. PubMed ID: 11363384.
    Abstract:
    Glaxo-Wellcome is developing a nucleoside analogue, 1529U89. The analogue shows potent in vitro activity against HIV, and initial tests of in-vivo efficacy are encouraging. The primary side effects of 1529U89 were nausea, headache, rash, and elevated liver function tests. Since the drug penetrates the central nervous system, participants are asked to allow spinal tips to measure the concentration of the drug in spinal fluid. Trials are being developed for 1529U89's use in AIDS-related dementia, and trials are being designed to test its effectiveness in combination with AZT and 3TC.
    [Abstract] [Full Text] [Related] [New Search]